316 related articles for article (PubMed ID: 21980052)
1. Metastatic adrenocortical carcinoma presenting simultaneously with Cushing's and Conn's syndromes: a case report.
Beom SH; Lee KW; Yang Y; Choi Y; Song KH; Kim YJ; Kim JH; Bang SM; Chung JH; Lee JS
Jpn J Clin Oncol; 2011 Nov; 41(11):1287-91. PubMed ID: 21980052
[TBL] [Abstract][Full Text] [Related]
2. Shift from Conn's syndrome to Cushing's syndrome in a recurrent adrenocortical carcinoma.
Barzon L; Masi G; Fincati K; Pacenti M; Pezzi V; Altavilla G; Fallo F; Palù G
Eur J Endocrinol; 2005 Nov; 153(5):629-36. PubMed ID: 16260420
[TBL] [Abstract][Full Text] [Related]
3. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
[TBL] [Abstract][Full Text] [Related]
5. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
7. [A case of adrenal cortical carcinoma].
Oida T; Souma T; Doi H; Hida S; Takasu K
Hinyokika Kiyo; 2002 Nov; 48(11):667-70. PubMed ID: 12512139
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical carcinoma.
van Ditzhuijsen CI; van de Weijer R; Haak HR
Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma. Our experience.
Favia G; Lumachi F; Carraro P; D'Amico DF
Minerva Endocrinol; 1995 Mar; 20(1):95-9. PubMed ID: 7651289
[TBL] [Abstract][Full Text] [Related]
10. Chromatin texture analysis of cortical adrenal gland adenomas, including incidentalomas, and adjacent normal-appearing cortical tissue.
Scarpelli M; Baccarini MG; Colanzi P; Arnaldi G; Montironi R; Thompson D; Bartels PH
Anal Quant Cytol Histol; 2000 Jun; 22(3):235-43. PubMed ID: 10872041
[TBL] [Abstract][Full Text] [Related]
11. Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma.
Malandrino P; Al Ghuzlan A; Castaing M; Young J; Caillou B; Travagli JP; Elias D; de Baere T; Dromain C; Paci A; Chanson P; Schlumberger M; Leboulleux S; Baudin E
Endocr Relat Cancer; 2010 Sep; 17(3):797-807. PubMed ID: 20592067
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and surgical treatment of arterial hypertension of adrenal origin].
Vetshev PS; Shkrob OS; Ippolitov LI; Polunin GV
Khirurgiia (Mosk); 2001; (1):33-40. PubMed ID: 11210311
[TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.
Pusantisampan T; Sangkhathat S; Kayasut K; Kanngurn S; Jaruratanasirikul S; Chotsampancharoen T; Kritsaneepaiboon S
Pediatr Dev Pathol; 2010; 13(3):238-42. PubMed ID: 19863445
[TBL] [Abstract][Full Text] [Related]
14. ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.
Yarom N; Stewart D; Avruch L; Malik R; Wells J; Jonker DJ
Anticancer Res; 2011 Nov; 31(11):3921-5. PubMed ID: 22110220
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of glutathione-peroxidase (GSH-PO) in human adrenal gland--studies on adrenocortical adenomas associated with primary aldosteronism and Cushing's syndrome.
Murakoshi M; Osamura RY; Yoshimura S; Watanabe K
Tokai J Exp Clin Med; 1995 Jul; 20(2):89-97. PubMed ID: 8797265
[TBL] [Abstract][Full Text] [Related]
16. [Isolated primary hyperaldosteronism caused by adrenocortical carcinoma].
Parajó A; Fírvida JL; Otero E; García M; Montero M
Arch Esp Urol; 2000 Dec; 53(10):931-4. PubMed ID: 11213398
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
[TBL] [Abstract][Full Text] [Related]
18. Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.
Hantel C; Jung S; Mussack T; Reincke M; Beuschlein F
Endocr Relat Cancer; 2014 Jun; 21(3):383-94. PubMed ID: 24532475
[TBL] [Abstract][Full Text] [Related]
19. Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
Kurtulmus N; Yarman S; Azizlerli H; Kapran Y
Horm Res; 2004; 62(2):67-70. PubMed ID: 15218335
[TBL] [Abstract][Full Text] [Related]
20. Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma. Case report and review of the literature.
Weingärtner K; Gerharz EW; Bittinger A; Rosai J; Leppek R; Riedmiller H
Urol Int; 1995; 55(4):232-5. PubMed ID: 8588274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]